Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.59 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.48 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.48 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.48 |
| ▸ | RET | P07949 | 1/20 | 0.48 |
| ▸ | MET | P08581 | 1/20 | 0.48 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.48 |
| ▸ | FLT1 | P17948 | 1/20 | 0.48 |
| ▸ | LTK | P29376 | 1/20 | 0.48 |
| ▸ | PRKX | P51817 | 1/20 | 0.48 |
| ▸ | NEK2 | P51955 | 1/20 | 0.48 |
| ▸ | JAK3 | P52333 | 1/20 | 0.48 |
| ▸ | BTK | Q06187 | 1/20 | 0.48 |
| ▸ | MAP4K2 | Q12851 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29531420 | 0.94 | SMN1; SMN2 (0.69) | SMN1; SMN2KMT2ALMNAKDM4EMAPT | |
| SCHEMBL14679630 | 0.94 | SMN1; SMN2 (0.69) | SMN1; SMN2KMT2ALMNAKDM4EMAPT | |
| SCHEMBL30208690 | 0.94 | SMN1; SMN2 (0.69) | SMN1; SMN2KMT2ALMNAKDM4EMAPT | |
| SCHEMBL19988082 | 0.91 | SMN1; SMN2 (0.50) | SMN1; SMN2KMT2ALMNAKDM4EMAPT | |
| SCHEMBL24763450 | 0.89 | KMT2A (0.49) | SMN1; SMN2KMT2ALMNAKDM4EMAPT | |
| SCHEMBL18731221 | 0.89 | SMN1; SMN2 (0.49) | SMN1; SMN2KMT2ALMNAKDM4EMAPT | |
| SCHEMBL6138102 | 0.87 | SMN1; SMN2 (0.63) | SMN1; SMN2KMT2ALMNAKDM4EMAPT | |
| SCHEMBL30340813 | 0.87 | SMN1; SMN2 (0.63) | SMN1; SMN2KMT2ALMNAKDM4EMAPT | |
| SCHEMBL17528670 | 0.87 | LMNA (0.46) | SMN1; SMN2KMT2ALMNAKDM4EMAPT | |
| SCHEMBL2450310 | 0.86 | SMN1; SMN2 (0.81) | SMN1; SMN2KMT2ALMNAKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023113475-A1 | POLYMER AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2023-06-22 | — | — | WO | disclosed |
| US-20230172057-A1 | HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2023-06-01 | — | — | US | disclosed |
| US-8840559-B2 | Organic piezoelectric material, ultrasonic oscillator using the material, method for manufacturing the ultrasonic oscillator, ultrasonic probe, and ultrasonic medical diagnostic imaging device | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2014-09-23 | — | — | US | disclosed |
| US-20110021916-A1 | ORGANIC PIEZOELECTRIC MATERIAL, ULTRASONIC OSCILLATOR USING THE MATERIAL, METHOD FOR MANUFACTURING THE ULTRASONIC OSCILLATOR, ULTRASONIC PROBE, AND ULTRASONIC MEDICAL DIAGNOSTIC IMAGING DEVICE | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2011-01-27 | — | — | US | disclosed |
| US-20110021918-A1 | ORGANIC PIEZOELECTRIC MATERIAL FILM, METHOD FOR PRODUCTION OF ORGANIC PIEZOELECTRIC MATERIAL FILM, METHOD FOR PRODUCTION OF ULTRASONIC OSCILLATOR, AND ULTRASONIC MEDICAL IMAGING INSTRUMENT | KONICA MINOLTA MEDICAL & GRAPHIC INC. (JP) | 2011-01-27 | — | — | US | disclosed |
| US-20110021917-A1 | ORGANIC PIEZOELECTRIC MATERIAL FILM, METHOD FOR PRODUCTION OF THE SAME, METHOD FOR PRODUCTION OF ULTRASONIC OSCILLATOR USING THE SAME, AND ULTRASONIC MEDICAL IMAGING INSTRUMENT | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2011-01-27 | — | — | US | disclosed |
| US-20110004102-A1 | ORGANIC PIEZOELECTRIC MATERIAL, ULTRASONIC OSCILLATOR USING THE SAME, METHOD FOR PRODUCING THE ULTRASONIC OSCILLATOR, ULTRASONIC PROBE AND ULTRASONIC MEDICAL DIAGNOSTIC IMAGING DEVICE | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2011-01-06 | — | — | US | disclosed |
| CN-101114085-A | Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display device | JSR CORP (JP) | 2008-01-30 | — | — | CN | disclosed |
| CN-101109873-A | Liquid crystal aligning agent,liquid crystal aligning film and liquid crystal display device | JSR CORP (JP) | 2008-01-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172057-A1 | HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE | CHRM1, CHRM2, CHRM4 | SMN1; SMN2 3262/4885KMT2A 2651/4885LMNA 2667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.